Cerebrovascular reactivity and disease activity in relapsing-remitting multiple sclerosis.


Journal

Advances in clinical and experimental medicine : official organ Wroclaw Medical University
ISSN: 1899-5276
Titre abrégé: Adv Clin Exp Med
Pays: Poland
ID NLM: 101138582

Informations de publication

Date de publication:
Feb 2020
Historique:
pubmed: 20 2 2020
medline: 29 7 2020
entrez: 20 2 2020
Statut: ppublish

Résumé

In multiple sclerosis (MS), insufficient blood supply might worsen energy deficiency of the brain tissue. Thus, cerebrovascular reactivity (CVR), which is the capacity of cerebral circulation to match blood supply to metabolic demand, might be important in MS pathology. The objective of this study was to investigate the relationship of CVR to disease activity and neuroimaging markers of disease progression in patients with MS. In 43 patients with relapsing remitting MS (RRMS) in clinical remission, 30 patients with a relapse of MS and 30 healthy controls, we measured CVR with transcranial Doppler as a relative change in flow velocity after breath-holding (breath-holding index) and voluntary hyperventilation (hyperventilation index). All patients in remission underwent brain magnetic resonance imaging at baseline and 33 underwent repeated imaging after 12 months, with various brain volume measurements taken. Cerebrovascular reactivity indices did not differ between patients in remission, patients with a relapse and controls. In patients in remission, CVR did not differ between those with or without contrast-enhancing lesions. In patients with a relapse, glucocorticoids significantly reduced both CVR indices. Cerebrovascular reactivity was not related to brain volume, white matter lesion volume, percent brain volume change, and the change in total white matter lesion volume. In RRMS, CVR appeared normal and unrelated to disease activity. There was no substantial association of CVR to brain atrophy and accumulation of white matter lesions.

Sections du résumé

BACKGROUND BACKGROUND
In multiple sclerosis (MS), insufficient blood supply might worsen energy deficiency of the brain tissue. Thus, cerebrovascular reactivity (CVR), which is the capacity of cerebral circulation to match blood supply to metabolic demand, might be important in MS pathology.
OBJECTIVES OBJECTIVE
The objective of this study was to investigate the relationship of CVR to disease activity and neuroimaging markers of disease progression in patients with MS.
MATERIAL AND METHODS METHODS
In 43 patients with relapsing remitting MS (RRMS) in clinical remission, 30 patients with a relapse of MS and 30 healthy controls, we measured CVR with transcranial Doppler as a relative change in flow velocity after breath-holding (breath-holding index) and voluntary hyperventilation (hyperventilation index). All patients in remission underwent brain magnetic resonance imaging at baseline and 33 underwent repeated imaging after 12 months, with various brain volume measurements taken.
RESULTS RESULTS
Cerebrovascular reactivity indices did not differ between patients in remission, patients with a relapse and controls. In patients in remission, CVR did not differ between those with or without contrast-enhancing lesions. In patients with a relapse, glucocorticoids significantly reduced both CVR indices. Cerebrovascular reactivity was not related to brain volume, white matter lesion volume, percent brain volume change, and the change in total white matter lesion volume.
CONCLUSIONS CONCLUSIONS
In RRMS, CVR appeared normal and unrelated to disease activity. There was no substantial association of CVR to brain atrophy and accumulation of white matter lesions.

Identifiants

pubmed: 32073765
doi: 10.17219/acem/114762
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

183-188

Auteurs

Łukasz Smoliński (Ł)

Second Department of Neurology, Institute of Psychiatry and Neurology, Warszawa, Poland.

Tomasz Litwin (T)

Second Department of Neurology, Institute of Psychiatry and Neurology, Warszawa, Poland.

Karolina Kruk (K)

Second Department of Neurology, Institute of Psychiatry and Neurology, Warszawa, Poland.

Marta Skowrońska (M)

Second Department of Neurology, Institute of Psychiatry and Neurology, Warszawa, Poland.

Iwona Kurkowska-Jastrzębska (I)

Second Department of Neurology, Institute of Psychiatry and Neurology, Warszawa, Poland.

Anna Członkowska (A)

Second Department of Neurology, Institute of Psychiatry and Neurology, Warszawa, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH